Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

BACKGROUND: Lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC) are bioactive lysophospholipids involved in the pathogenesis of renal diseases, especially the renal fibrosis. Plasma LPC concentrations in chronic kidney disease (CKD) patients are lower or similar to those observed in contro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lipids Health Dis
Hlavní autoři: Michalczyk, Anna, Dołęgowska, Barbara, Heryć, Rafał, Chlubek, Dariusz, Safranow, Krzysztof
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449907/
https://ncbi.nlm.nih.gov/pubmed/30947711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-019-1040-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky